Gazyva

­
  • Gazyva

Gazyva

Facts of Gazyva 1000mg Vial ?

  • Medicine Name: GAZYVA
  • Medicine Name: Obinutuzumab
  • Date of Approval:
  • Company Name: Genentech, Inc.
Category:

Product Description

What is GAZYVA ?

GAZYVA, in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia (CLL)

GAZYVA (obinutuzumab) is a humanized anti-CD20 monoclonal antibody of the IgG1 subclass. It recognizes a specific epitope of the CD20 molecule found on B-cells. The molecular mass of the antibody is approximately 150 kDa.

GAZYVA is produced by mammalian cell (CHO) suspension culture. GAZYVA is a sterile, clear, colorless to slightly brown, preservative free liquid concentrate for intravenous administration. GAZYVA is supplied at a concentration of 25 mg/mL in 1000 mg single use vials. The product is formulated in 20 mM L-histidine/ L-histidine hydrochloride, 240 mM trehalose, 0.02 % poloxamer 188. The pH is 6.0.

How supplied/storage and handling ?

GAZYVA 1000 mg/40 mL (25 mg/mL) single-use vials containing preservative-free solution (NDC 50242-070-01) are stable at 2°C to 8°C (36°F to 46°F). Do not use beyond expiration date stamped on carton. GAZYVA vials should be protected from light. DO NOT FREEZE. DO NOT SHAKE.

Reviews

There are no reviews yet.

Be the first to review “Gazyva”